Literature DB >> 20559615

Measuring the level of diagnostic concordance and discordance between modules of the CIDI-Short Form and the CIDI-Auto 2.1.

Matthew Sunderland1, Gavin Andrews, Tim Slade, Lorna Peters.   

Abstract

PURPOSE: The Composite International Diagnostic Interview-Short Form (CIDI-SF) is a short disorder-specific diagnostic interview for common mental disorders. Many researchers have been attracted to the CIDI-SF because of its brevity and cost effectiveness. As a result, the CIDI-SF has been used in multiple epidemiological studies and clinical trials. Despite the widespread use, a search of literature has revealed relatively few validation studies. This investigation aims to provide estimates of concordance and discordance between the CIDI-SF disorder modules and the full CIDI, as well as providing evidence regarding the potential screening utility of the CIDI-SF.
METHODS: The sample comprised 83 patients attending a tertiary referral clinic for anxiety disorders. Patients were administered the CIDI-SF and the full CIDI-Auto and estimates of agreement between the two measures were calculated. Interview transcripts were examined for cases that disagreed on a diagnosis to elicit a likely reason for the lack of agreement between the two measures. Finally, the screening properties of the dimensionally scored CIDI-SF were calculated and compared with the Depression Anxiety Stress Scale.
RESULTS: The CIDI-SF tended to overestimate the rate of diagnoses as evidenced by a high degree of false positives. However, the CIDI-SF exhibited favorable screening properties (ruling out non-disordered cases).
CONCLUSIONS: These results suggest that caution must be taken when using the CIDI-SF as the sole diagnostic instrument in epidemiological research to estimate prevalence and incidence. The CIDI-SF may be more useful for screening out potential candidates in clinical research and psychopharmacological trials.

Entities:  

Mesh:

Year:  2010        PMID: 20559615     DOI: 10.1007/s00127-010-0247-6

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  37 in total

1.  Diagnosing mental disorders in the community. A difference that matters?

Authors:  H U Wittchen; T B Ustün; R C Kessler
Journal:  Psychol Med       Date:  1999-09       Impact factor: 7.723

2.  The design of Healthcare for Communities: a study of health care delivery for alcohol, drug abuse, and mental health conditions.

Authors:  R Sturm; C Gresenz; C Sherbourne; K Minnium; R Klap; J Bhattacharya; D Farley; A S Young; M A Burnam; K B Wells
Journal:  Inquiry       Date:  1999       Impact factor: 1.730

Review 3.  Kappa coefficients in medical research.

Authors:  Helena Chmura Kraemer; Vyjeyanthi S Periyakoil; Art Noda
Journal:  Stat Med       Date:  2002-07-30       Impact factor: 2.373

Review 4.  Pretesting survey instruments: an overview of cognitive methods.

Authors:  Debbie Collins
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

5.  Weighted 2 x 2 kappa coefficients: recommended indices of diagnostic accuracy for evidence-based practice.

Authors:  James M Gilchrist
Journal:  J Clin Epidemiol       Date:  2009-03-10       Impact factor: 6.437

Review 6.  The psychometric properties of the Composite International Diagnostic Interview.

Authors:  G Andrews; L Peters
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  1998-02       Impact factor: 4.328

7.  Long-term medical conditions and major depression in a Canadian population study at waves 1 and 2.

Authors:  S B Patten
Journal:  J Affect Disord       Date:  2001-03       Impact factor: 4.839

Review 8.  Making psychiatric epidemiology useful: the contribution of epidemiology to government policy.

Authors:  R Jenkins
Journal:  Acta Psychiatr Scand       Date:  2001-01       Impact factor: 6.392

Review 9.  Measuring the accuracy of diagnostic systems.

Authors:  J A Swets
Journal:  Science       Date:  1988-06-03       Impact factor: 47.728

10.  Use of telephone screens improves efficiency of healthy subject recruitment.

Authors:  Helene Adami; Amie Elliott; Millie Zetlmeisl; Robert McMahon; Gunvant Thaker
Journal:  Psychiatry Res       Date:  2002-12-30       Impact factor: 3.222

View more
  7 in total

1.  Recall of recent and more remote depressive episodes in a prospective cohort study.

Authors:  Scott B Patten; Jeanne V A Williams; Dina H Lavorato; Andrew G M Bulloch; Carl D'Arcy; David L Streiner
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-05-01       Impact factor: 4.328

2.  Mental disorders in primary care in Israel: prevalence and risk factors.

Authors:  Neil Laufer; Nelly Zilber; Pablo Jecsmien; Binyamin Maoz; Daniel Grupper; Haggai Hermesh; Royi Gilad; Abraham Weizman; Hanan Munitz
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-01-04       Impact factor: 4.328

3.  Developing a short-form structured diagnostic interview for common mental disorders using signal detection theory.

Authors:  Matthew Sunderland; Tim Slade; Gavin Andrews
Journal:  Int J Methods Psychiatr Res       Date:  2012-11-06       Impact factor: 4.035

4.  Most antidepressant use in primary care is justified; results of the Netherlands Study of Depression and Anxiety.

Authors:  Ellen Piek; Klaas van der Meer; Witte J G Hoogendijk; Brenda W J H Penninx; Willem A Nolen
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

5.  Referral of patients with depression to mental health care by Dutch general practitioners: an observational study.

Authors:  Ellen Piek; Klaas van der Meer; Brenda W J H Penninx; Peter F M Verhaak; Willem A Nolen
Journal:  BMC Fam Pract       Date:  2011-05-26       Impact factor: 2.497

6.  Maintenance use of antidepressants in Dutch general practice: non-guideline concordant.

Authors:  Ellen Piek; Boudewijn J Kollen; Klaas van der Meer; Brenda W J H Penninx; Willem A Nolen
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

7.  Psychedelics and mental health: a population study.

Authors:  Teri S Krebs; Pål-Ørjan Johansen
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.